Previous Close | 3.0600 |
Open | 4.5300 |
Bid | 2.0000 |
Ask | 6.0000 |
Strike | 270.00 |
Expire Date | 2024-05-17 |
Day's Range | 2.0000 - 4.7700 |
Contract Range | N/A |
Volume | |
Open Interest | 347 |
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.
On May 15, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.